Creative Medical Technology Holdings, Inc. SEC filings CELZ
Creative Medical Technology Holdings, Inc. has 409 filings in SEC EDGAR's recent list, going back to Sep 13, 2002. Its latest annual report, Form 10-K, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 25, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Aug 3, 2026 | — |
| S-3 | Shelf registration | Jul 24, 2026 | — |
| S-1/A | Amended registration statement | Jun 26, 2026 | — |
| S-1 | Registration statement | Jun 25, 2026 | — |
| 424B3 | Prospectus | Dec 16, 2025 | — |
| S-3 | Shelf registration | Nov 21, 2025 | — |
| 424B3 | Prospectus | Apr 15, 2025 | — |
| S-3 | Shelf registration | Apr 2, 2025 | — |
| 424B3 | Prospectus | Nov 20, 2024 | — |
| S-1 | Registration statement | Nov 8, 2024 | — |
| 424B5 | Prospectus supplement | Oct 23, 2024 | — |
| S-3 | Shelf registration | Oct 4, 2024 | — |
| 424B3 | Prospectus | May 20, 2022 | — |
| S-3 | Shelf registration | May 10, 2022 | — |
| S-1 | Registration statement | Apr 22, 2022 | — |
| 424B4 | Prospectus | Dec 6, 2021 | — |
| S-1/A | Amended registration statement | Dec 2, 2021 | — |
| S-1/A | Amended registration statement | Dec 1, 2021 | — |
| S-1/A | Amended registration statement | Nov 23, 2021 | — |
| S-1 | Registration statement | Sep 28, 2021 | — |
| POS AM | Filing | Feb 22, 2017 | — |
| 424B3 | Prospectus | Dec 14, 2016 | — |
| S-1 | Registration statement | Nov 21, 2016 | — |
| S-1 | Registration statement | Nov 5, 2008 | — |
Showing 24 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CELZ (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Phoenix, AZ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1187953
- Former names
- JOLLEY MARKETING INC (until May 13, 2016)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.